Bioactive coating to prevent catheter infection and thrombosis
Peripheral and central venous catheters are among the most implanted blood-contacting medical devices for short and long-term clinical applications, respectively. Despite implementations of in-hospital measures, catheters are ofte...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
Coati-X
New generation of bioactive coating for intravenous catheter...
2M€
Cerrado
NOVO
Novel approaches for prevention and degeneration of pathogen...
4M€
Cerrado
PRE2020-093041
RECUBRIMIENTOS DE HIDROGEL QUE CONTIENEN NANOPARTICULAS ANTI...
99K€
Cerrado
PID2019-104111RB-I00
RECUBRIMIENTOS DE HIDROGEL QUE CONTIENEN NANOPARTICULAS ANTI...
157K€
Cerrado
COATIM
Development of antibiofilm coatings for implants
4M€
Cerrado
Duración del proyecto: 24 meses
Fecha Inicio: 2019-10-23
Fecha Fin: 2021-10-31
Líder del proyecto
UNIVERSITE DE LIEGE
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
150K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Peripheral and central venous catheters are among the most implanted blood-contacting medical devices for short and long-term clinical applications, respectively. Despite implementations of in-hospital measures, catheters are often subject to infection and thrombotic complications, which result in longer hospitalization stay, higher health care costs, or even death. The CMD-COAT project aims at providing an innovative and rapid solution to this major medical, economical and societal need. The solution comes from our patented technology, referred to as Coatigel, that consists of grafting multilayer cross-linked nanogels with combined antifouling, antimicrobial and antithrombotic properties onto catheter surface. The combination of these properties can guarantee longer catheter clinical performance than any currently available products. Our project includes all the validation steps that will enable us to bring Coatigel on the catheter market. We will assess Coatigel compliance with ISO standards and compile the technical file for CE mark application in accordance with EU directives for class III medical devices. The whole process will be realized under the guidance of a company specialized in quality management to ensure optimal reliability and efficacy. The project also involves setting up partnerships with catheter industries to adjust our technology to manufacturing constraints. Via services of marketing experts, we will take on a competitive market analysis, including geographic segmentation, to position Coatigel in the catheter market. This project will result in the creation of a coating spin-off company with the exclusive right of Coatigel commercial exploitation. The presence of several big catheter manufacturers in Belgium is a main asset for our business success. All this will be achieved thanks to the help of local support in intellectual property management, consolidating industrial partnerships, and in contacts with potential investors.